Johnson & Johnson · 6 hours ago
Associate Director, HEMA Provider Relations
Maximize your interview chances
Health CareMedical Device
Comp. & BenefitsH1B Sponsor Likely
Insider Connection @Johnson & Johnson
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Execute customer facing Provider Relation strategies for JJMTS products/procedures/services focused on expanding the dissemination of HEMA evidence.
Deploy tailored strategies to address provider requirements for priority products/procedures/services (i.e., evidence dissemination initiatives or programs)
Integrate customer insights and understanding of the reimbursement landscape into the development of customer programs and materials.
Partner with key HEMA functions to deploy provider resources, such as reimbursement hotlines, tools, economic models, real-world data dashboards, etc.
Lead and/or support priority market access initiatives/capabilities, as assigned, such as, but not limited to, local market access initiatives, integrated payer-provider relations strategies, reimbursement/market access assessments, reimbursement hotline management, evidence dissemination workstreams, internal/external training, etc.)
Support innovative/value-based contracting initiatives including, but not limited to customer engagement, dissemination of evidence and coordination of other HEMA functions
Monitor changes in reimbursement and provider landscape impacting priority areas and translates them into insights and recommendations.
Partner with other HEMA functions and business partners to create internally disseminate insights to help shape and inform business strategy
Establish strong collaboration and partnership across HEMA and with business partners to align on priorities, goals and objectives, including cadence of communication and reporting metrics.
Partner to deploy integrated payer-provider strategies and other local market access strategies which require closely engagement and collaborations with providers, when applicable
Promote innovative approaches to expand the impact of the Provider Relations and US HEMA teams
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
A minimum of a Bachelor’s degree required.
A minimum of 5+ years of experience in the Medical Device, Pharmaceutical or Health plan industry and track record delivering business impact that includes health economic evidence communication, health policy, and reimbursement.
Ability to work from strategy development to execution and value creation in a dynamic organization is required
Previous US market experience with a strong understanding of medical delivery systems, reimbursement, market access conditions and health policy trends in the US is required.
Solid knowledge of evidence needed to drive favorable US reimbursement and market access is required.
Strong communication skills with the ability to effectively present, communicate and disseminate complex data and concepts.
Up to 50% Domestic Travel
Preferred
Master’s degree in health policy, health service research, business administration public health, public policy, health administration, health economics or economics
US market development/therapy expansion/commercial experience
Previous experience with Medical Devices health economic evidence communication and reimbursement
Benefits
Annual performance bonus
Company
Johnson & Johnson
Johnson & Johnson develops medical devices, pharmaceuticals, and consumer packaged goods.
H1B Sponsorship
Johnson & Johnson has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (43)
2022 (55)
2021 (40)
2020 (30)
Funding
Current Stage
Public CompanyTotal Funding
unknown1944-09-24IPO
Recent News
Pharma Letter
2024-12-18
Company data provided by crunchbase